60 Degrees Pharmaceuticals Llc

This study tests whether adding an oral drug called tafenoquine to standard antibiotics helps hospitalized adults with babesiosis recover faster. Babesiosis is a tick-borne illness that can cause fever, chills, and fatigue. About 33 participants will receive either tafenoquine or…

This program provides access to an experimental drug called tafenoquine for immunocompromised adults who have a persistent Babesia infection that hasn't cleared with standard treatments. Patients take the drug orally, starting with daily doses and then switching to weekly doses, …

This study is testing whether the drug tafenoquine can help people with chronic babesiosis who suffer from severe, disabling fatigue. The main goal is to see if the treatment reduces fatigue levels and clears the Babesia parasite from the body. Researchers will enroll 40 adults a…